Table 4.
Sub analysis of patients with clinical improvements
| Sub-analysis of those with improvements* | Median change (IQR) | Change in step count | |||
|---|---|---|---|---|---|
| Decreased | Maintained | Increased | |||
| Weight loss (lb) | 15^ (45.5%) | − 7 (− 12.9, − 2) | 2 | 9 | 2 |
| ≥ 5% weight loss | 6 (18.2%) | ||||
| Reduction in ALT (U/L) | 17^ (51.5%) | − 30 (− 78, − 11) | 2 | 12 | 2 |
| Reduction to < 35 | 10 (33.3%) | ||||
| Reduction in TG (mg/dL) | 21 (63.6%) | − 2.5 (− 6.5, − 0.3) | 4 | 14 | 3 |
| Reduction to < 150 | 9 (31%) | ||||
| Reduction in liver stiffness (kPa) | 14^ (42.4%) | − 12 (− 26, − 6) | 2 | 10 | 1 |
| ≥ 10% Reduction in kPa | 7 (30.4%) | ||||
| Reduction in CAP (dB/m) | 14^ (42.4%) | − 46 (− 85, − 20) | 3 | 13 | 2 |
| ≥ 10% Reduction in CAP | 7 (50%) | ||||
| Increase in 6MWT (feet) | 23^ (69.6%) | 140 (35–255) | 4 | 14 | 3 |
| 6MWT > population mean | 5 (17.9%) | ||||
Bolded values indicate result was significant with P value of 0.05 or less
*Top row for each variable represents number of participants with any improvement for that variable. Second row for each variable represents number of participants with more marked improvement
^2 patients missing 6-month step count data for weight loss and 6MWT; 1 patient had missing 6-month step count data for reduction in ALT, kPa and CAP